Cargando…
Metformin Resistance Is Associated with Expression of Inflammatory and Invasive Genes in A549 Lung Cancer Cells
Metformin, the most commonly used drug for type 2 diabetes, has recently been shown to have beneficial effects in patients with cancer. Despite growing evidence that metformin can inhibit tumor cell proliferation, invasion, and metastasis, studies on drug resistance and its side effects are lacking....
Autores principales: | Seo, Dong Soo, Joo, Sungmin, Baek, Seungwoo, Kang, Jaehyeon, Kwon, Taeg Kyu, Jang, Younghoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218153/ https://www.ncbi.nlm.nih.gov/pubmed/37239373 http://dx.doi.org/10.3390/genes14051014 |
Ejemplares similares
-
Metformin mediated microRNA-7 upregulation inhibits growth, migration, and invasion of non-small cell lung cancer A549 cells
por: Dong, Jingying, et al.
Publicado: (2020) -
Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways
por: Morelli, Ana Paula, et al.
Publicado: (2021) -
Activation of caspases and inhibition of ribosome biogenesis mediate antitumor activity of Chijongdan in A549 non-small lung cancer cells
por: Kim, Bo Geun, et al.
Publicado: (2014) -
An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib
por: Kwon, Taeho, et al.
Publicado: (2015) -
Alpha-mangostin inhibits the migration and invasion of A549 lung cancer cells
por: Phan, Thi Kieu Trang, et al.
Publicado: (2018)